Patients and Health Advocates in Support of Proposed Changes to the PMPRB and a National Pharmacare Program

I support the change for the welfare of the population.

Medications are a part of our health care and should be accessible to all, regardless of their income!

La pauvreté des personnes agées est reconnue. Ce sont eux qui prennent le plus de médicaments.

7 years ago Featured

We need to begin to reverse the trend to extend patent rights which is so damaging to our health care system and to access to affordable medicines. The Canadian government must stop promoting private patent monopolies and start considering how to make pharmaceuticals more accessible to patients at affordable prices. We need a national phamacare plan in which the Federal government finally takes some responsibility for access to affordable medicines

I totally support this petition

Always wasting money (useless/dangerous/expensive to taxpayers mammography screening) then ripping off Canadians to give to Big Pharma

This is very necessary!

Access to health should not only be or the wealthy.

This is extremely important for all of us and our healthcare

We can use the overcharged amounts to get more needed medicines to people who are not getting them now.

7 years ago Featured

Director, Breast Cancer Action Quebec. Unconscionably high drug prices cause so much distress and inaccessibility. Breast Cancer Action Quebec refuses all pharma funding. How any patient advocacy group can be against a reform that brings more effective medicines to more people at reasonable prices is incomprehensible. (Except of course if you accept pharma funding.)

Yes

Clinical developmental nurse

Doing what I can to support because I love my mom.

I give my full support

Expect government action on this important ingredient to our public health care. Thank you

I couldn’t support this more

Laval, Québec

The need for these changes is amply documented and long overdue.

As President of Consumers Council, I note need for Canadians to have fully competitive pharmaceuticals pricing. Any patients’ groups against generic alternatives need to be both better informed and fully independent of pharma influence.